Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tau Finanziaria Spa Sigma currently holds 252,469 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tau Finanziaria Spa Sigma has been a net seller of SCLN stock. They have purchased $25.4M and sold $47.3M worth of shares.
Tau Finanziaria Spa Sigma's most recent insider trade was on Apr 30, 2012, when they sold 6,328,469 shares at $5.25 per share.
Tau Finanziaria Spa Sigma serves as Executive at SCICLONE PHARMACEUTICALS INC (SCLN). They have executed 26 insider transactions totaling $72.7M over their tenure at the company.
Tau Finanziaria Spa Sigma holds the position of Executive at SCICLONE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Tau Finanziaria Spa Sigma has shown a selling trading pattern, with $25.4M in total purchases and $47.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Tau Finanziaria Spa Sigma was on Apr 30, 2012, when they sold $33.2M worth of SCLN shares. This transaction involved 6,328,469 shares at $5.25 per share.
Tau Finanziaria Spa Sigma currently owns 252,469 shares of SCICLONE PHARMACEUTICALS INC (SCLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tau Finanziaria Spa Sigma's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tau Finanziaria Spa Sigma has 26 Form 4 filings on record as an insider at SCICLONE PHARMACEUTICALS INC.
Set alerts for Tau Finanziaria Spa Sigma and 40,000+ other insiders.